临床疗效

术后1个月

术后3个月

CR

2 (5.00%)

1 (2.50%)

PR

23 (57.50%)

25 (62.50%)

SD

12 (30.00%)

10 (25.00%)

PD

3 (7.50%)

4 (10.00%)

ORR (CR + PR)

62.50%

65.00%

DCR (CR + PR + SD)

92.50%

90.00%